Moreover, our in vitro and in vivo data showing strong chemosensitization upon inhibiting FAK or Src kinases suggest that FAK/Src axis is critical for tumor cell survival in the presence of chemotherapy and targeting these proteins could also be an effective strategy to overcome chemoresistance in TNBCs in the future. Here, SRC is linked to neoplasm.